IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+5.14%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$156M
AUM Growth
+$156M
(-13%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-12.47%
Top 10 Holdings %
Top 10 Hldgs %
41.87%
Holding
82
New
17
Increased
14
Reduced
14
Closed
23
Top Buys
| 1 |
Eli Lilly
LLY
|
$4.12M |
| 2 |
Sanofi
SNY
|
$3.59M |
| 3 |
Cigna
CI
|
$2.93M |
| 4 |
AbbVie
ABBV
|
$2.9M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$2.47M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.2M |
| 2 |
MDCO
Medicines Co
MDCO
|
$3.8M |
| 3 |
SHPG
Shire pic
SHPG
|
$3.51M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$2.91M |
| 5 |
Merck
MRK
|
$2.88M |
Sector Composition
| 1 | Healthcare | 79.02% |
| 2 | Financials | 3.16% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $12.7M | 7.16% | 97,500 +7,500 | +8% | +$974K |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $7.3M | 4.13% | 60,000 +10,000 | +20% | +$1.22M |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $7.02M | 3.97% | 75,000 +25,000 | +50% | +$2.34M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $6.61M | 3.74% | 40,000 -21,250 | -35% | -$3.51M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $6.08M | 3.44% | 25,000 +7,500 | +43% | +$1.82M |
|
|
MDCO
6
DELISTED
Medicines Co
MDCO
| $5.7M | 3.22% | 150,000 -100,000 | -40% | -$3.8M |
|
|
7
Merck
MRK
$210B
| $5.13M | 2.9% | 80,000 -45,000 | -36% | -$2.88M |
|
|
AERI
8
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.99M | 2.82% | 95,000 +10,000 | +12% | +$525K |
|
|
AET
9
DELISTED
Aetna Inc
AET
| $4.93M | 2.79% | 32,500 -17,500 | -35% | -$2.66M |
|
|
KTWO
10
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.87M | 2.75% | 200,000 | – | – |
|
|
GBT
11
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.79M | 2.71% | 175,000 -25,000 | -13% | -$684K |
|
12
Ultragenyx Pharmaceutical
RARE
$2.89B
| $4.66M | 2.63% | 75,000 | – | – |
|
13
Esperion Therapeutics
ESPR
$448M
| $4.63M | 2.62% | 100,000 +25,000 | +33% | +$1.16M |
|
|
SPNC
14
DELISTED
Spectranetics Corp
SPNC
| $4.22M | 2.39% | 110,000 +35,000 | +47% | +$1.34M |
|
|
15
Eli Lilly
LLY
$657B
| $4.12M | 2.33% | +50,000 | New | +$4.12M |
|
|
DERM
16
DELISTED
Dermira, Inc.
DERM
| $4.08M | 2.31% | 140,000 | – | – |
|
|
17
Sanofi
SNY
$121B
| $3.59M | 2.03% | +75,000 | New | +$3.59M |
|
18
Zimmer Biomet
ZBH
$21B
| $3.21M | 1.81% | 25,000 +10,000 | +67% | +$1.28M |
|
|
JUNO
19
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.99M | 1.69% | 100,000 | – | – |
|
|
20
Cigna
CI
$80.3B
| $2.93M | 1.66% | +17,500 | New | +$2.93M |
|
|
21
AbbVie
ABBV
$372B
| $2.9M | 1.64% | +40,000 | New | +$2.9M |
|
|
IMMU
22
DELISTED
Immunomedics Inc
IMMU
| $2.87M | 1.62% | 325,000 -25,000 | -7% | -$221K |
|
23
Merus
MRUS
$4.98B
| $2.77M | 1.57% | 175,000 | – | – |
|
24
Karyopharm Therapeutics
KPTI
$61.7M
| $2.72M | 1.53% | 300,000 +25,000 | +9% | +$226K |
|
|
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
| $2.69M | 1.52% | 35,000 -5,000 | -13% | -$385K |
|